N/A
N=851
Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)
Major Depressive Disorder
Bottom Line
View on ClinicalTrials.gov: NCT00770289 ↗Enrolled (actual)
851
Serious AEs
—
Results posted
Aug 2012
Primary outcome: Primary: Percentage of Participants With Remission Based on Hamilton Depression Scale (HAM-D) — 54.4 Percentage of participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Cohort (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Pfizer
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Remission Based on Hamilton Depression Scale (HAM-D) |
54.4 | — |
| SECONDARY Percentage of Participants With Remission Based on Beck Depression Inventory (BDI) |
64.6 | — |
| SECONDARY Hamilton Depression Scale 17 (HAM-D17), HAM-D7 and Beck Depression Inventory (BDI) |
25.18; 13.53; 31.45; 7.31; 4.07; 9.03 | <0.0001 sig |
| SECONDARY Number of Participants With Residual Symptoms in Case of Non Remission |
59; 35; 22; 22; 20; 4 | — |
Summary
Tools known as 'depression scales 'are widely used as assessments to evaluate a patient's response to treatment. The purpose of this study is the evaluation of the remission rates for patients with MDD. The evaluation will involve the use of HAM-D 17, and HAM-D 7 questionnaires and the comparison of those questionnaires.
Eligibility Criteria
Inclusion Criteria
- Outpatients
- 18-75 years old
- Patients diagnosed with MDD according to DSM IV without psychotic symptoms
- HAM-D17 > or = 18 on inclusion
- Patients receiving treatment for the first time or changing treatment based on their doctor's decision
Exclusion Criteria
- Subjects with potentially problematic compliance
- Subjects participating in an interventional trial within the last 3 months
Data sourced from ClinicalTrials.gov (NCT00770289). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.